High Tech Pharm Co., Ltd. (KOSDAQ:106190)
South Korea · Delayed Price · Currency is KRW 11,750
+300 (2.62%)
At close: Aug 14, 2026
High Tech Pharm Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 124,940 | 127,811 | 148,864 | 99,208 | 77,268 | 97,116 | |
Market Cap Growth | -5.47% | -14.14% | 50.05% | 28.39% | -20.44% | -25.75% |
Enterprise Value | 116,493 | 114,996 | 153,628 | 111,271 | 89,346 | 110,402 |
Last Close Price | 11750.00 | 12020.00 | 13825.00 | 9147.57 | 7075.37 | 8836.82 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.93 | 11.14 | 10.86 | 12.28 | 13.16 | - |
PS Ratio | 1.81 | 1.82 | 1.92 | 1.29 | 0.75 | 1.33 |
PB Ratio | 0.97 | 0.98 | 1.24 | 0.93 | 0.77 | 1.03 |
P/TBV Ratio | 0.97 | 0.98 | 1.24 | 0.93 | 0.77 | 1.03 |
P/FCF Ratio | 61.54 | 8.46 | 11.85 | - | - | 16.00 |
P/OCF Ratio | 32.17 | 7.51 | 10.13 | 34.11 | - | 14.02 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.69 | 1.64 | 1.98 | 1.45 | 0.87 | 1.51 |
EV/EBITDA Ratio | 7.94 | 6.29 | 7.41 | 7.38 | 8.53 | 21.49 |
EV/EBIT Ratio | 12.66 | 8.95 | 9.88 | 11.03 | 18.13 | - |
EV/FCF Ratio | 57.38 | 7.62 | 12.23 | - | - | 18.19 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0 | 0 | 0.07 | 0.15 | 0.16 | 0.17 |
Debt / EBITDA Ratio | 0.00 | 0.00 | 0.39 | 1.09 | 1.57 | 3.11 |
Debt / FCF Ratio | 0.01 | 0.00 | 0.64 | - | - | 2.63 |
Net Debt / Equity Ratio | -0.07 | -0.11 | 0.00 | 0.10 | 0.09 | 0.04 |
Net Debt / EBITDA Ratio | -0.57 | -0.79 | 0.01 | 0.74 | 0.82 | 0.65 |
Net Debt / FCF Ratio | -4.16 | -0.95 | 0.02 | -5.10 | -1.96 | 0.55 |
Asset Turnover | 0.48 | 0.50 | 0.56 | 0.57 | 0.81 | 0.58 |
Inventory Turnover | 1.27 | 1.36 | 1.92 | 3.18 | 5.88 | 3.86 |
Quick Ratio | 1.52 | 2.06 | 1.48 | 1.31 | 1.15 | 0.97 |
Current Ratio | 4.62 | 5.67 | 3.39 | 2.48 | 1.64 | 1.78 |
Return on Equity (ROE) | 7.23% | 9.16% | 12.09% | 7.81% | 6.06% | -1.30% |
Return on Assets (ROA) | 4.01% | 5.66% | 7.07% | 4.72% | 2.41% | -0.21% |
Return on Invested Capital (ROIC) | 6.45% | 9.03% | 10.48% | 7.29% | 4.79% | -0.41% |
Return on Capital Employed (ROCE) | 7.10% | 9.80% | 12.80% | 9.00% | 4.90% | -0.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.22% | 8.98% | 9.21% | 8.14% | 7.60% | -1.26% |
FCF Yield | 1.63% | 11.82% | 8.44% | -2.20% | -5.64% | 6.25% |
Payout Ratio | 11.78% | 9.27% | 5.17% | 6.14% | 6.04% | - |
Buyback Yield / Dilution | -0.64% | -0.64% | -49.99% | 33.33% | - | - |